Closure of Space for health - PEL(13)05 (PDF 38KB)

This Professional Estates Letter informs HSC bodies of the closure of the Space for Health information service and the availability of DHSPPS estates and facilities management policy on the DHSSPS website.

Speech, Language and Communication Therapy Action Plan (2011/12 - 2012/13) - Easy Read (PDF 454 KB)

Easy Read version of Speech, Language and Communication Therapy Action Plan (2011/12 - 2012/13)

Equality Impact Assessment of the Oral Health Strategy (PDF 120 KB)

The Health and Personal Social Services (Northern Ireland) Order 1972 requires the Department of Health, Social Services and Public Safety to provide or secure the provision of health services in Northern Ireland designed to promote the physical and mental health of the community through the prevention, diagnosis and treatment of illness. This includes the provision of oral health care. åÊ åÊ

Anàlisi de les variables relacionades amb la reincidència dels agressors sexuals. Estudi d’una mostra d’interns de les presons de Catalunya

Les taxes de reincidència dels delinqüents sexuals son, en general més baixes que les de la resta de delinqüents. No obstant, hi ha una part que tenen una major probabilitat de tornar a delinquir i que tenen unes característiques de risc que els diferencien dels altres. S’ha dut a terme un estudi retrospectiu amb la totalitat dels delinqüents sexuals que van sortir de les presons de Catalunya entre l’1 de gener de 1998 i el 31 de desembre de 2001. El període de seguiment promig és de sis anys i nou mesos. S’han avaluat les taxes de reincidència en delictes sexuals, delictes no sexuals (generals) i en qualsevol tipus de delicte. Un 5,7 % va tornar a delinquir en delictes sexuals, el 13,2 dels subjectes va reincidir en delictes no sexuals i el 18,8 % va tornar a cometre qualsevol tipus de delicte. Entre les variables de risc, el nombre de delictes sexuals pels que compleixen condemna abans de sortir en llibertat i el tipus de víctima influeixen en la reincidència sexual, encara que respecte a la segona no es va poder calcular la significació estadística. També van tenir un pes significatiu l’edat del primer ingrés i la versatilitat delictiva. Pel que fa a la reincidència general, les variables relacionades amb la carrera delictiva i trets antisocials, a més de les condicions de la condemna, van ser les variables de més influencia. No s’ha trobat relació entre el tractament i la reincidència. Posteriorment a l’estudi d’aquestes variables van ser entrevistats vuit dels 11 subjectes que havien reincidit en delictes sexuals. A partir de l’anàlisi de les entrevistes es va elaborar un sistema de classificació dels principals components del procés del delicte. De la revisió del procés de cada subjecte apareixen dos perfils diferenciats.

Fascitis eosinofílica. A propósito de 13 casos.

Es tracta de la descripció d'una sèrie de 13 pacients amb fascitis eosinofílica diagnosticats en un hospital universitari entre 1989 i 2009. És una síndrome esclerodermiforme que es caracteritza per induració cutània i engruiximent i inflamació de la fàscia profunda. Es descriuen les característiques clíniques, el tractament rebut i l'evolució de 9 homes i 4 dones, amb una edat mitjana de 50 anys. Es va realitzar biòpsia profunda en tots els casos i els canvis van ser compatibles amb fascitis eosinofílica. Les característiques descrites en aquesta sèrie no difereixen de les descrites per altres autors.

Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension.

BACKGROUND: The impact of osmotic therapies on brain oxygen has not been extensively studied in humans. We examined the effects on brain tissue oxygen tension (PbtO(2)) of mannitol and hypertonic saline (HTS) in patients with severe traumatic brain injury (TBI) and refractory intracranial hypertension. METHODS: 12 consecutive patients with severe TBI who underwent intracranial pressure (ICP) and PbtO(2) monitoring were studied. Patients were treated with mannitol (25%, 0.75 g/kg) for episodes of elevated ICP (>20 mm Hg) or HTS (7.5%, 250 ml) if ICP was not controlled with mannitol. PbtO(2), ICP, mean arterial pressure, cerebral perfusion pressure (CPP), central venous pressure and cardiac output were monitored continuously. RESULTS: 42 episodes of intracranial hypertension, treated with mannitol (n = 28 boluses) or HTS (n = 14 boluses), were analysed. HTS treatment was associated with an increase in PbtO(2) (from baseline 28.3 (13.8) mm Hg to 34.9 (18.2) mm Hg at 30 min, 37.0 (17.6) mm Hg at 60 min and 41.4 (17.7) mm Hg at 120 min; all p<0.01) while mannitol did not affect PbtO(2) (baseline 30.4 (11.4) vs 28.7 (13.5) vs 28.4 (10.6) vs 27.5 (9.9) mm Hg; all p>0.1). Compared with mannitol, HTS was associated with lower ICP and higher CPP and cardiac output. CONCLUSIONS: In patients with severe TBI and elevated ICP refractory to previous mannitol treatment, 7.5% hypertonic saline administered as second tier therapy is associated with a significant increase in brain oxygenation, and improved cerebral and systemic haemodynamics.

Studies on the production and regulation of interleukin, IL-13, IL-4 and interferon-gamma in human Schistosomiasis mansoni

The production and regulation of interleukin (IL) IL-13, IL-4 and interferon-gamma was evaluated in different clinical forms of human schistosomiasis. The mechanisms of immune regulation are apparently different in the various clinical stages of the disease, some of them being antigen specific.

Action Plan For Health Research 2009 - 13

The purpose of this overviews to set the scene so as to assist with a fuller understanding of the Action Plan. It begins by outlining the purpose and objectives of the Action Plan. This is followed by the identificaton of the changes that the Action Plan will bring about over its time frame. The overview concludes by elaborating the structure and philosophy of the Action Plan.

Implementation of the Action Plan for Health Research 2009-13 - First year report 2009-2010

In November 2009 the Government published an Action Plan for Health Research. The Plan was prepared by the Health Research Group following a commitment set out in Building Ireland’s Smart Economy (December 2008). The Action Plan, which was approved by the Cabinet Committee on Science, Technology and Innovation, provides the lead on national priorities and resource allocation in health research. The Action Plan was prepared to prioritise a programme of actions essential to creating a health research system which supports outstanding individuals, working in world class facilities and conducting leading edge research focused on the needs of patients and the public. The HRG is committed to measuring the success of the Action Plan by the extent to which it meets these deliverables by 2013. One year on, this report reviews the progress being made to implement the Plan.  

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.

To assess the role of arginine vasopressin (AVP) in congestive heart failure (CHF), 10 patients with CHF refractory to conventional treatment were studied before and 60 minutes after intravenous administration of 5 micrograms/kg of d(CH2)5Tyr(Me)AVP, a specific antagonist of AVP at the vascular receptor level. Heart rate, systemic arterial pressure, pulmonary arterial pressure, pulmonary capillary wedge pressure, cardiac index by thermodilution and cutaneous blood flow by laser-Doppler technique were measured. In 9 patients with no significant hemodynamic and cutaneous blood flow response to the AVP antagonist, baseline values (mean +/- standard deviation) were: heart rate, 77 +/- 14 beats/min; systemic arterial pressure, 120/79 +/- 18/8 mm Hg; pulmonary arterial pressure, 42/21 +/- 12/8 mm Hg; pulmonary capillary wedge pressure, 19 +/- 7 mm Hg; cardiac index, 2.2 +/- 0.6 liters/min/m2; plasma AVP, 2.3 +/- 0.8 pg/ml; and plasma osmolality, 284 +/- 14 mosm/kg H2O. The tenth patient had the most severe CHF. His plasma AVP level was 55 pg/ml and plasma osmolality was 290 mosm/kg. He responded to the AVP antagonist with a decrease in systemic arterial pressure from 115/61 to 79/41 mm Hg, in pulmonary arterial pressure from 58/31 to 33/13 mm Hg and in pulmonary capillary wedge pressure from 28 to 15 mm Hg. Simultaneously, cardiac index increased from 1.1 to 2.2 liters/min/m2 and heart rate from 113 to 120 beats/min; cutaneous blood flow increased 5-fold.(ABSTRACT TRUNCATED AT 250 WORDS)

Beating cervical cancer: information for girls in Year 9, aged 12-13 (English and eight translations)

This leaflet is distributed to girls in Year 9 and explains about the HPV vaccine which can help protect against cervical cancer.